Papuloerythroderma of Ofuji

From WikiMD's WELLNESSPEDIA


Papuloerythroderma of Ofuji
Synonyms Ofuji's disease
Pronounce N/A
Specialty Dermatology
Symptoms Pruritus, erythroderma, papules
Complications N/A
Onset Typically in adulthood
Duration Chronic
Types N/A
Causes Unknown, possibly immune system related
Risks Male gender, elderly age
Diagnosis Clinical diagnosis, skin biopsy
Differential diagnosis Psoriasis, eczema, drug eruption
Prevention N/A
Treatment Systemic corticosteroids, phototherapy, immunosuppressive therapy
Medication N/A
Prognosis Variable, can be chronic and relapsing
Frequency Rare
Deaths N/A


Papuloerythroderma of Ofuji is a rare skin condition first described by Japanese dermatologists Ofuji et al. in 1984. It is characterized by the presence of red, flat, and slightly elevated papules that tend to coalesce into large plaques. The disease is more common in elderly individuals and has been associated with various internal malignancies.

Clinical Features[edit]

The primary clinical feature of Papuloerythroderma of Ofuji is the presence of red, flat, and slightly elevated papules. These papules often coalesce to form large plaques that cover a significant portion of the body. The plaques are typically symmetrical and have a characteristic "deck-chair" distribution, sparing the skin folds. Other symptoms may include pruritus, fever, and malaise.

Pathogenesis[edit]

The exact cause of Papuloerythroderma of Ofuji is unknown. However, it is believed to be a reactive process triggered by various factors such as drugs, infections, and malignancies. The disease has been associated with various internal malignancies, including lymphoma and gastric cancer.

Diagnosis[edit]

Diagnosis of Papuloerythroderma of Ofuji is primarily based on clinical features. Skin biopsy may be performed to rule out other conditions. Laboratory tests may be conducted to identify any underlying malignancies.

Treatment[edit]

Treatment of Papuloerythroderma of Ofuji primarily involves managing the symptoms and treating any underlying conditions. Topical corticosteroids and systemic therapies such as cyclosporine and methotrexate may be used.

Prognosis[edit]

The prognosis of Papuloerythroderma of Ofuji is generally good, especially when the underlying condition is treated. However, the disease tends to recur and may require long-term management.


See Also[edit]

References[edit]

  • Ofuji S, Furukawa F, Miyachi Y, Ohnishi Y, Hamada T, Hashimoto I. Papuloerythroderma. Dermatologica. 1984;169(3):125-30.
  • Taniguchi S, Hamada T, Hashimoto I, Furukawa F, Ofuji S. Papuloerythroderma associated with gastric cancer. Dermatologica. 1986;172(4):209-13.
  • Miyachi Y, Niwa Y. Papuloerythroderma. Dermatologica. 1987;175(5):242-7.

External Links[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.